Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 2 | Unknown | — |
The patient took Vivotif vaccine everyday instead of one every other day; Case reference number US-BN-2025-001153 is a spontaneous case initially received from pharmacist via Communication (reference number: USBAV25-1625) on 07-Jul-2025 and concern male patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient took unspecified number of doses of Vivotif (batch number: unknown) at an unknown dose and route for unknown indication, as reported the patient took Vivotif vaccine everyday instead of one every other day (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of initial report, it was unknown if the patient experienced any adverse events due to Vivotif. No further information was provided.; Reporter's Comments: This case concerns a male patient of unspecified age, who received unspecified doses of Vivotif vaccine, everyday instead of one every other day, for an unknown indication, which is considered as 'inappropriate schedule of product administered'. Inappropriate schedule of product administered is considered as listed per company convention. At the time of initial report, it was unknown if the patient experienced any adverse events due to Vivotif. The patient's relevant medical history and concomitant medication details were not provided. Inappropriate schedule of product administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: This case concerns a male patient of unspecified age, who received unspecified doses of Vivotif vaccine, everyday instead of one every other day, for an unknown indication, which is considered as 'inappropriate schedule of product administered'. Inappropriate schedule of product administered is considered as listed per company convention. At the time of initial report, it was unknown if the patient experienced any adverse events due to Vivotif. The patient's relevant medical history and concomitant medication details were not provided. Inappropriate schedule of product administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.